Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts

Area of Science:

• Biochemistry
• Cell Biology
• Enzymology

Background:

• Prostaglandin endoperoxide H synthases (PGHS-1 and PGHS-2) synthesize prostanoids using arachidonic acid.
• Studies suggest PGHS-1 and PGHS-2 utilize distinct arachidonic acid pools.
• Understanding differential substrate utilization is crucial for targeted therapeutic development.

Purpose of the Study:

• Investigate the mechanism behind differential arachidonic acid utilization by PGHS-1 and PGHS-2.
• Determine the role of intracellular conditions in regulating PGHS activity.
• Clarify the specific conditions under which PGHS-2 becomes active in intact cells.

Main Methods:

• Utilized cultured murine NIH3T3 fibroblasts for experiments.
• Employed histofluorescence staining to assess PGHS activity in intact cells.
• Analyzed arachidonic acid conversion in both cell-free systems and intact cells under varying conditions.
• Investigated the effect of reducing agents (sodium selenite, ebselen) on PGHS activity.

Main Results:

• Quiescent cells showed PGHS-1 activity; serum-activated cells pretreated with aspirin exhibited PGHS-2 activity.
• Endogenous arachidonic acid was exclusively converted by PGHS-2, not PGHS-1, in intact cells.
• PGHS-2, but not PGHS-1, converted low concentrations (below 2.5 microM) of arachidonic acid in intact cells.
• Reducing agents specifically reduced PGHS-2 activity, suggesting peroxide involvement.

Conclusions:

• PGHS-2 exclusively utilizes low concentrations of endogenously released arachidonic acid in intact cells.
• Intracellular peroxides likely activate PGHS-2, enabling its conversion of endogenous arachidonic acid.
• Findings highlight the distinct regulatory mechanisms and substrate preferences of PGHS-1 and PGHS-2 in vivo.